US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.080
  • -0.010-0.32%
Close Dec 13 16:00 ET
  • 3.080
  • 0.0000.00%
Post 19:58 ET
321.52MMarket Cap-1.60P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
RHA ® Collection of dermal fillers30.5M50.94%
DaxibotulinumtoxinA-lanm (DAXXIFY ®)28.32M47.30%
Collaboration revenue1.05M1.76%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States234.04M100.00%
Heat List
US
Overall
Symbol
Price
% Chg

No Data